Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced ‘robust’ immune response

by Raphael Stevens 14 July 2020, 22:04 109 Views

Moderna’s potential vaccine to prevent Covid-19 produced neutralizing antibodies in all 45 patients in its early stage human trial, according to newly released data.

DeFi Will be an Integral Part of the Lives of Many, CEO of Crypto Exchange OKEx

Internal U.S. small business watchdog launches inquiry into duplicate pandemic loans

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced ‘robust’ immune response

DeFi Will be an Integral Part of the Lives of Many, CEO of Crypto Exchange OKEx

Internal U.S. small business watchdog launches inquiry into duplicate pandemic loans

ITALIAN LANGUAGE

ENGLISH LANGUAGE